Israeli Biological Institute: Gaucher’s Disease Drugs Effective Against COVID-19, Ready For Immediate Use

2

NES TZIONA (VINnews) — The Nes-Tziona-based Institute for Biological Research, which is affiliated with Israel’s Defense Ministry, announced Tuesday that it has found that two drugs used to treat a genetic disorder known as Gaucher’s disease are also effective against the coronavirus and potentially against other viruses as well.One of these drugs -Cerdelga – is already certified for use by the FDA and the other one- Venglustat -has almost completed the approval process, so that both drugs can be transferred almost immediately for use with COVID-19 patients

Join our WhatsApp group

Subscribe to our Daily Roundup Email


In the proposed antiviral treatment, the two drugs would be taken together.

“The two drugs under development are currently being tested for their effectiveness in treating animals infected with the coronavirus,” the ministry said. The institute has already published the results of a study of the treatment on mice, though the article has yet to be peer-reviewed. The study found that the medications inhibited the replication of the viruses in the bodies of the infected animals.

In addition to being effective against the coronavirus, the treatment was also found to work against three other viruses, Neuro-invasive Sindbis virus, West Nile virus and Influenza A virus, the researchers wrote.

“This indicates their potential in treating various viral diseases effectively — including future outbreaks of new viruses — once they are clinically approved,” the ministry wrote.

Gaucher’s disease is a genetic disorder common among Ashkenazi Jews. The researchers found that the drugs used to treat this disease cause the creation of molecules called glycosphingolipids that appear to serve an antiviral function, according to their article.

In recent weeks the Biological Institute announced that it was patenting certain antibodies which it believed could be useful in treating COVID-19. Last week, Channel 12 news reported that the laboratory had completed successful vaccine trials on rodents, paving the way to further testing on other animals and then eventually human trials. The laboratory hopes to have a finished vaccine in a year, or possibly earlier, the report said.

About 100 research groups around the world are pursuing vaccines for the coronavirus, with nearly a dozen in early stages of human trials or poised to start. But so far there is no way to predict which — if any — vaccine will work safely, or even to name a front-runner.


Listen to the VINnews podcast on:

iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

Follow VINnews for Breaking News Updates


Connect with VINnews

Join our WhatsApp group


2 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
a yid
a yid
3 years ago

thank you for the informaTION

Normal
Normal
3 years ago

As someone said, let the boycotters boycott.